Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruckstuhl

Showing results (251-260 of 418) with videos related to

Pageof 42
Sort By:
Journal for Immunotherapy of Cancer|February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicityTamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
Physical Review Letters|February 11, 1985
Charged D production in e+e- annihilation at 29 GeV and a limit on D0-D-bar 0 mixingYamamoto, Atwood, Baillon, et al.
Nature Structural & Molecular Biology|March 24, 2020
Engineering and functionalization of large circular tandem repeat protein nanoparticlesColin E Correnti, Jazmine P Hallinan, Lindsey A Doyle, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
PLOS Global Public Health|April 24, 2025
Facility readiness for decentralized Package of Essential Noncommunicable Disease Interventions-Plus (PEN-Plus) care in nine lower-income countriesLaura Drown, Alma J Adler, Devashri Salvi, et al.
Plos One|June 6, 2024
qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissueShalini Pullarkat, Graeme Black, Marie Bleakley, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2024
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial MalignanciesCarla A Jaeger-Ruckstuhl, Jennifer M Specht, Jenna M Voutsinas, et al.
Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.
Pageof 42

Showing results (251-260 of 418) with videos related to

Sort By:
Pageof 42
Journal for Immunotherapy of Cancer|February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicityTamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
Physical Review Letters|February 11, 1985
Charged D production in e+e- annihilation at 29 GeV and a limit on D0-D-bar 0 mixingYamamoto, Atwood, Baillon, et al.
Nature Structural & Molecular Biology|March 24, 2020
Engineering and functionalization of large circular tandem repeat protein nanoparticlesColin E Correnti, Jazmine P Hallinan, Lindsey A Doyle, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
PLOS Global Public Health|April 24, 2025
Facility readiness for decentralized Package of Essential Noncommunicable Disease Interventions-Plus (PEN-Plus) care in nine lower-income countriesLaura Drown, Alma J Adler, Devashri Salvi, et al.
Plos One|June 6, 2024
qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissueShalini Pullarkat, Graeme Black, Marie Bleakley, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2024
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial MalignanciesCarla A Jaeger-Ruckstuhl, Jennifer M Specht, Jenna M Voutsinas, et al.
Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.
Pageof 42